When should Ribavirin be Considered
I.Severe respiratory syncytial virus bronchiolitis
II.Congenital immunodeficiency
III.Inpatients admitted to hospital with bronchiolitis
IV.Routine protoCol as part of respiratory management of bronchiolitis
V.Bone marrow transplant
VI.Acute lung disease

Question

Quizplus · Accepted Answer

Ribavirin is considered for use in severe cases of respiratory syncytial virus (RSV) bronchiolitis, particularly in patients with congenital immunodeficiency or those who have undergone a bone marrow transplant, due to their increased risk of severe infection and complications.

When Should Ribavirin Be Considered